NMRA 8-K 2026-10-30

Neumora Therapeutics, Inc. (NMRA) 8-K dated 2026-10-30 — accession 0001193125-26-441634.

Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.

Neumora Therapeutics, Inc. filed a 8-K on 2026-10-30. Accession 0001193125-26-441634.

This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for NMRA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The NMRA SEC hub lists recent forms. The stock page is the research view.